Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Liraglutide Global Market Report 2025
Request Sample Buy Now
Global Liraglutide Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Liraglutide Global Market Report 2025

By Brands (Victoza, Saxenda), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies And Drug Stores, Online Pharmacies), By Type Of Application (Diabetes Treatment, Weight Management), By End-Users (Hospitals And Clinics, Homecare Settings) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Liraglutide Market Overview

• Liraglutide market size has reached to $6.38 billion in 2024

• Expected to grow to $9.45 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%

• Growth Driver: Impact Of Diabetic Population Growth On The Liraglutide Market

• Market Trend: Expansion Of Generic GLP-1 Products In The Liraglutide Market

• North America was the largest region and fastest growing region.

What Is Covered Under Liraglutide Market?

Liraglutide is a GLP-1 receptor agonist used to manage type 2 diabetes and obesity. It helps lower blood sugar levels and promotes weight loss by mimicking the incretin hormone GLP-1. Administered via subcutaneous injection, IT enhances insulin secretion and reduces appetite. Liraglutide is marketed under the brand names Victoza for diabetes and Saxenda for obesity.

The main liraglutide brands are victoza and saxenda. Victoza is a brand name for liraglutide, a medication used to treat type 2 diabetes. It can be distributed through hospital pharmacies, retail pharmacies, drug stores, and online pharmacies, and IT is used for diabetes treatment and weight management. It is used by various end-users, including hospitals, clinics, and home care settings.

Liraglutide Market Size and growth rate 2025 to 2029: Graph

What Is The Liraglutide Market Size 2025 And Growth Rate?

The liraglutide market size has grown strongly in recent years. It will grow from $6.38 billion in 2024 to $6.88 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to the increasing number of people diagnosed with type 2 diabetes, growing obesity rates, extensive clinical trials, growing awareness of diabetes complications, and rising innovations in drug delivery systems.

What Is The Liraglutide Market Growth Forecast?

The liraglutide market size is expected to see strong growth in the next few years. It will grow to $9.45 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing insurance and reimbursement policies, healthcare infrastructure development, increasing awareness and educational initiatives, a growing aging population, and the increasing prevalence of diabetes. Major trends in the forecast period include the use of artificial intelligence and machine learning, demand for wearable technology, continuous glucose monitoring integration, biotechnology advancements, and the development of digital health platforms.

The forecast of 8.3% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for U.S. endocrinology practices by increasing costs of glucagon-like peptide-1 receptor agonist therapies manufactured in Denmark and Austria, potentially reducing diabetes and obesity treatment accessibility and raising metabolic disorder care expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Liraglutide Market Segmented?

1) By Brands: Victoza, Saxenda

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Drug Stores, Online Pharmacies

3) By Type Of Application: Diabetes Treatment, Weight Management

4) By End-Users: Hospitals And Clinics, Homecare Settings

Subsegments:

1) By Victoza: Type 2 Diabetes Treatment Or Weight Management

2) By Saxenda: Weight Loss Treatment Or Obesity Management

What Is Driving The Liraglutide Market? Impact Of Diabetic Population Growth On The Liraglutide Market

The increasing diabetic population is expected to propel the growth of the liraglutide market going forward. Diabetes is a chronic condition where the body cannot properly regulate blood sugar levels, either due to insufficient insulin production or ineffective insulin use. The incidence of diabetes is increasing due to factors such as sedentary lifestyles, unhealthy diets, and rising obesity rates worldwide. Diabetes drugs such as liraglutide help by mimicking the action of the hormone GLP-1, which enhances insulin secretion, lowers blood sugar levels, and promotes weight loss, thereby aiding in the management of type 2 diabetes.For instance, in March 2024, according to a report by the Government of the United Kingdom, a UK-based information website, In March 2023, the proportion of people with type 1 diabetes in England receiving all 8 care processes at GP practices involved in the NDA increased to 43.8%, compared to 35.2% the year before. Therefore, the increasing diabetic population is driving the growth of the liraglutide industry.

Who Are The Major Players In The Global Liraglutide Market?

Major companies operating in the liraglutide market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, Takeda Pharmaceutical Company Limited, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy's Laboratories Ltd., Biocon Limited, Hanmi Pharmaceutical Co. Ltd., Intarcia Therapeutics Inc., Adocia SA

What Are The Key Trends Of The Global Liraglutide Market? Expansion Of Generic GLP-1 Products In The Liraglutide Market

Major companies operating in the liraglutide market are developing novel products, such as generic GLP-1, to expand treatment options and address market demand for more affordable alternatives. Generic GLP-1 refers to versions of GLP-1 receptor agonists that are produced after the expiration of patent protection on the original branded medications, offering cost-effective alternatives for treating conditions like type 2 diabetes and obesity. For instance, in June 2024, Teva Pharmaceutical Industries Ltd., an Israel-based pharmaceutical company, introduced the first generic GLP-1, similar to Victoza, in the U.S. market, meeting the rising demand for these therapies. Liraglutide injections are prescribed to enhance blood sugar management in adults and children aged 10 and above with type 2 diabetes and to lower the risk of cardiovascular incidents in adults with type 2 diabetes and existing cardiovascular conditions.

Need data on a specific region in this market?
Request Customisation

What Are Latest Mergers And Acquisitions In The Liraglutide Market? Biocon Limited And Juno Pharmaceuticals Partner To Commercialize Liraglutide In Canada

In October 2023, Biocon Limited, an India-based biopharmaceutical company, partnered with Juno Pharmaceuticals to commercialize its vertically integrated, complex formulation, Liraglutide. Under the terms of this partnership agreement, Biocon will be responsible for obtaining regulatory approval for Liraglutide and, thereafter, for the manufacture and supply of the product in the Canadian market. Juno Pharmaceuticals is a Canada-based pharmaceutical company that focuses on bringing complex and high-value generic and biosimilar products to the market.

What Is The Regional Outlook For The Global Liraglutide Market?

North America was the largest region in the liraglutide market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Liraglutide Market?

The liraglutide market consists of sales of insulin products, weight management supplements, nutritional supplements, and related products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Liraglutide Industry?

The liraglutide market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the liraglutide industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Liraglutide Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $6.88 billion
Revenue Forecast In 2034 $9.45 billion
Growth Rate CAGR of 8.3% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Brands: Victoza, Saxenda
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Drug Stores, Online Pharmacies
3) By Type Of Application: Diabetes Treatment, Weight Management
4) By End-Users: Hospitals And Clinics, Homecare Settings Subsegments: 1) By Victoza: Type 2 Diabetes Treatment Or Weight Management
2) By Saxenda: Weight Loss Treatment Or Obesity Management
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, Takeda Pharmaceutical Company Limited, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy's Laboratories Ltd., Biocon Limited, Hanmi Pharmaceutical Co. Ltd., Intarcia Therapeutics Inc., Adocia SA
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Liraglutide Market Characteristics

3. Liraglutide Market Trends And Strategies

4. Liraglutide Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Liraglutide Growth Analysis And Strategic Analysis Framework

5.1. Global Liraglutide PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Liraglutide Market Growth Rate Analysis

5.4. Global Liraglutide Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Liraglutide Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Liraglutide Total Addressable Market (TAM)

6. Liraglutide Market Segmentation

6.1. Global Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Victoza

Saxenda

6.2. Global Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Retail Pharmacies And Drug Stores

Online Pharmacies

6.3. Global Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Diabetes Treatment

Weight Management

6.4. Global Liraglutide Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Clinics

Homecare Settings

6.5. Global Liraglutide Market, Sub-Segmentation Of Victoza, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Type 2 Diabetes Treatment

Weight Management

6.6. Global Liraglutide Market, Sub-Segmentation Of Saxenda, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Weight Loss Treatment

Obesity Management

7. Liraglutide Market Regional And Country Analysis

7.1. Global Liraglutide Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Liraglutide Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Liraglutide Market

8.1. Asia-Pacific Liraglutide Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Liraglutide Market

9.1. China Liraglutide Market Overview

9.2. China Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Liraglutide Market

10.1. India Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Liraglutide Market

11.1. Japan Liraglutide Market Overview

11.2. Japan Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Liraglutide Market

12.1. Australia Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Liraglutide Market

13.1. Indonesia Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Liraglutide Market

14.1. South Korea Liraglutide Market Overview

14.2. South Korea Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Liraglutide Market

15.1. Western Europe Liraglutide Market Overview

15.2. Western Europe Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Liraglutide Market

16.1. UK Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Liraglutide Market

17.1. Germany Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Liraglutide Market

18.1. France Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Liraglutide Market

19.1. Italy Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Liraglutide Market

20.1. Spain Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Liraglutide Market

21.1. Eastern Europe Liraglutide Market Overview

21.2. Eastern Europe Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Liraglutide Market

22.1. Russia Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Liraglutide Market

23.1. North America Liraglutide Market Overview

23.2. North America Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Liraglutide Market

24.1. USA Liraglutide Market Overview

24.2. USA Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Liraglutide Market

25.1. Canada Liraglutide Market Overview

25.2. Canada Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Liraglutide Market

26.1. South America Liraglutide Market Overview

26.2. South America Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Liraglutide Market

27.1. Brazil Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Liraglutide Market

28.1. Middle East Liraglutide Market Overview

28.2. Middle East Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Liraglutide Market

29.1. Africa Liraglutide Market Overview

29.2. Africa Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Liraglutide Market Competitive Landscape And Company Profiles

30.1. Liraglutide Market Competitive Landscape

30.2. Liraglutide Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Liraglutide Market Other Major And Innovative Companies

31.1. Bristol-Myers Squibb Company

31.2. AstraZeneca PLC

31.3. Novartis International AG

31.4. Takeda Pharmaceutical Company Limited

31.5. GlaxoSmithKline Plc

31.6. Eli Lilly and Company

31.7. Amgen Inc.

31.8. Boehringer Ingelheim International GmbH

31.9. Novo Nordisk A/S

31.10. Teva Pharmaceutical Industries Ltd.

31.11. Cipla Limited

31.12. Dr. Reddy's Laboratories Ltd.

31.13. Biocon Limited

31.14. Hanmi Pharmaceutical Co. Ltd.

31.15. Intarcia Therapeutics Inc.

32. Global Liraglutide Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Liraglutide Market

34. Recent Developments In The Liraglutide Market

35. Liraglutide Market High Potential Countries, Segments and Strategies

35.1 Liraglutide Market In 2029 - Countries Offering Most New Opportunities

35.2 Liraglutide Market In 2029 - Segments Offering Most New Opportunities

35.3 Liraglutide Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Liraglutide Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Liraglutide Market, Sub-Segmentation Of Victoza, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Liraglutide Market, Sub-Segmentation Of Saxenda, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Liraglutide Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Liraglutide Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Pfizer Inc. Financial Performance
  • Table 78: Roche Holding AG Financial Performance
  • Table 79: Merck & Co. Inc. Financial Performance
  • Table 80: AbbVie Inc. Financial Performance
  • Table 81: Sanofi S.A. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Liraglutide Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Liraglutide Market, Sub-Segmentation Of Victoza, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Liraglutide Market, Sub-Segmentation Of Saxenda, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Liraglutide Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Liraglutide Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Liraglutide Market, Segmentation By Brands, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Liraglutide Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Liraglutide Market, Segmentation By Type Of Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Pfizer Inc. Financial Performance
  • Figure 78: Roche Holding AG Financial Performance
  • Figure 79: Merck & Co. Inc. Financial Performance
  • Figure 80: AbbVie Inc. Financial Performance
  • Figure 81: Sanofi S.A. Financial Performance

Strategic Growth Drivers Shaping the Nutraceutical Excipients Market Outlook 2025- 2034:The Role Of Health And Wellness In Driving Growth In The Nutraceutical Excipients Market

Read More About Strategic Growth Drivers Shaping the Nutraceutical Excipients Market Outlook 2025- 2034:The Role Of Health And Wellness In Driving Growth In The Nutraceutical Excipients Market

Emerging Growth Drivers in the Opioids Market Landscape: Growing Surgical Procedures Fueling Demand In The Opioids Market

Read More About Emerging Growth Drivers in the Opioids Market Landscape: Growing Surgical Procedures Fueling Demand In The Opioids Market

Osimertinib Drugs Market Outlook 2025–2034: Identifying Growth Drivers, Technology Trends, and Policy Impact

Read More About Osimertinib Drugs Market Outlook 2025–2034: Identifying Growth Drivers, Technology Trends, and Policy Impact

Otic Drugs Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

Read More About Otic Drugs Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Read More About Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Explore forecast data, therapeutic advancements, and pipeline progress in TBRC’s Tuberous Sclerosis Drug Market report.

Read More About Explore forecast data, therapeutic advancements, and pipeline progress in TBRC’s Tuberous Sclerosis Drug Market report.

Gain insights into strategic developments and market forecasts for the tissue plasminogen activator market.

Read More About Gain insights into strategic developments and market forecasts for the tissue plasminogen activator market.

Automotive Power Discrete Global Market Report 2025 – By Product (Gallium Nitride (GaN), Silicon Carbide (SiC)), By Devices (Power Integrated Circuits (IC), Power Module Or Discrete), By Component (Microcontroller, Senso...

View Report

Anticoagulants Global Market Report 2025 – By Drug Class (Factor Xa Inhibitor, Heparin And LMWH, Vitamin K Antagonist, Other Drug Classes), By Route Of Administration (Oral Anticoagulant, Injectable Anticoagulant), By Di...

View Report

Veterinary Infectious Disease Diagnostics Global Market Report 2025 – By Infection Type (Viral Infections, Bacterial Infections, Parasitic Infections, Other Infections), By Animal Type (Companion Animal, Food-Producing a...

View Report

Compression Therapy Global Market Report 2025 – By Product (Compression Pumps, Compression Stockings, Compression Bandages, Compression Tapes), By Technique (Static Compression Therapy, Dynamic Compression Therapy), By A...

View Report

Amorphous Polypropylene Terephthalate Global Market Report 2025 - By Additives (Chain Extenders, Nucleating Agents, Solid Stating Accelerators, Impact Modifiers, Other Additives), By Application (Bottles, Films/Sheets, F...

View Report

Frequently Asked Questions

Liraglutide is a GLP-1 receptor agonist used to manage type 2 diabetes and obesity. It helps lower blood sugar levels and promotes weight loss by mimicking the incretin hormone GLP-1. Administered via subcutaneous injection, it enhances insulin secretion and reduces appetite. Liraglutide is marketed under the brand names Victoza for diabetes and Saxenda for obesity. For further insights on this market, request a sample here

The market major growth driver - Impact Of Diabetic Population Growth On The Liraglutide Market. For further insights on this market, request a sample here

The liraglutide market size has grown strongly in recent years. It will grow from $6.38 billion in 2024 to $6.88 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to the increasing number of people diagnosed with type 2 diabetes, growing obesity rates, extensive clinical trials, growing awareness of diabetes complications, and rising innovations in drug delivery systems. The liraglutide market size is expected to see strong growth in the next few years. It will grow to " $9.45 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing insurance and reimbursement policies, healthcare infrastructure development, increasing awareness and educational initiatives, a growing aging population, and the increasing prevalence of diabetes. Major trends in the forecast period include the use of artificial intelligence and machine learning, demand for wearable technology, continuous glucose monitoring integration, biotechnology advancements, and the development of digital health platforms. For further insights on this market, request a sample here

The liraglutide market covered in this report is segmented –
1) By Brands: Victoza, Saxenda
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Drug Stores, Online Pharmacies
3) By Type Of Application: Diabetes Treatment, Weight Management
4) By End-Users: Hospitals And Clinics, Homecare Settings Subsegments:
1) By Victoza: Type 2 Diabetes Treatment Or Weight Management
2) By Saxenda: Weight Loss Treatment Or Obesity Management For further insights on this market, request a sample here

North America was the largest region in the liraglutide market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the liraglutide market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the liraglutide market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, Takeda Pharmaceutical Company Limited, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy's Laboratories Ltd., Biocon Limited, Hanmi Pharmaceutical Co. Ltd., Intarcia Therapeutics Inc., Adocia SA . For further insights on this market, request a sample here.

Major trends in this market include Expansion Of Generic GLP-1 Products In The Liraglutide Market. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Liraglutide Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon